Ares Genetics News Today

BURLINGAME, Calif., Nov. 22, 2023 /PRNewswire/ — According to Coherent Market Insights, Global Artificial Intelligence (AI) in Genomics market size was valued at US$ 1.15 Billion in 2023 and is expected to surpass US$ 19.72 Billion by 2030 and is anticipated to witness a compound annual growth rate (CAGR) of 50.1% from 2023 to 2030. The global […]

Artificial Intelligence (AI) in Genomics Market to Surpass US$ 19.72 Billion by 2030 - Coherent Market Insights

/PRNewswire/ -- According to Coherent Market Insights, Global Artificial Intelligence (AI) in Genomics market size was valued at US$ 1.15 Billion in 2023 and...

-- OpGen said late Wednesday that it struck a deal to sell 1,000 shares of its series D preferred stock to a single investor to raise $1 million for its operations while it pursues a potential...

OpGen, Inc. (NASDAQ:OPGN) Q2 2023 Earnings Call Transcript August 10, 2023 OpGen, Inc. misses on earnings expectations. Reported EPS is $-0.93 EPS, expectations were $-0.71. Operator: Welcome to OpGen’s Second Quarter 2023 Earnings Call and Business Update. Before we turn the call over to OpGen management, please note that any forward-looking statements made during this […]

Operator: Welcome to the OpGen First Quarter 2023 Earnings Call and Business Update.

15.05.2023 - Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero UTI De Novo FDA submission and Unyvero ...

ROCKVILLE, Md., May 01, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power...

PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, GermanyTotal project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03,... | April 3, 2023

Operator: Welcome to the OpGen Fourth Quarter and Full Year 2022 Earnings Call and Business Update.